£3.7M
The oversubscribed financing round was funded entirely by the company's existing investor base.
PlaqueTec
PlaqueTec develops intracoronary liquid biopsy technology to identify inflammatory drivers of cardiovascular disease.
£10.1MTotal raised
PlaqueTec is a medical technology company developing intracoronary liquid biopsy techniques to uncover inflammatory drivers of cardiovascular disease. The firm builds proprietary proteomic datasets to support targeted therapeutic development and patient stratification.
Categories
Team
MS
Martin Stapleton
Chairman
Investors
Funding history
£6.4M
The funding will support the ongoing BIOPATTERN trial and the expansion of the BIOCARTA database.